Skip to content

Christopher Pittenger

27 papers in the library · 511 citations · publishing 2017-2026

Papers

Sort Most recent Most cited

Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment Refractory Obsessive-Compulsive Disorder

Journal of Clinical Psychopharmacology April 1, 2017 Thomas G. Adams, M. Bloch, Christopher Pittenger

To the Editors: R efractory obsessive-compulsive disorder (OCD) is a common and vexing clinical problem. Agents that modulate glutamate, including theN-methyl-Daspartate antagonist ketamine, have been the focus of recent interest for the treatment of this population, but experience to date has been mixed. Ketamine is a rapid-acting antidepressant that enhances cellular mechanisms associated...

Who Is Reached by Supervised Psilocybin Services? Oregon Services Versus National Psilocybin Use

Gabriel P. A. Costa, Christina Riggione, Christopher Pittenger et al.

Supervised psilocybin services are expanding across the United States, yet how individuals accessing these programs compare with those using psilocybin in the general population is unknown. We conducted a cross-sectional descriptive comparison of Oregon Psilocybin Services (OPS) data from licensed service centers in 2025 (5,935 encounters) and the 2024 National Survey on Drug Use and Health...